Woodline Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Woodline Partners's ASND Position: Q3 2026 in Review
Woodline Partners held its Ascendis Pharma (ASND) position steady in Q3 2026 at 102,469 shares worth $23.3M. The position accounts for 0.07% of the portfolio, ranked #361.
Woodline Partners first reported a position in ASND in Q4 2019 and has held it in 19 quarters since. The position peaked at $52.7M in Q2 2025. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Woodline Partners held 102,469 shares of Ascendis Pharma worth $23.3M as of Q3 2026.
- Woodline Partners left its Ascendis Pharma share count unchanged in Q3 2026.
- Ascendis Pharma made up 0.07% of Woodline Partners's portfolio in Q3 2026, its #361 holding.
- Woodline Partners first reported a position in Ascendis Pharma in Q4 2019 and has held it in 19 quarters since.
- Woodline Partners's Ascendis Pharma position peaked at $52.7M in Q2 2025.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.